VIP and neoplasm: NfpNETs produce no clear clinical symptoms until a late stage, while functioning tumours are associated with hormonal syndromes due to their active secretion of biological amines and hormones such as insulin (17%), gastrin (15%), vasoactive intestinal peptide (VIP, 2%), glucagon (1%) and somatostatin (1%) [5,6,7].